The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
genentech | 14286 |
roche | 3320 |
array biopharma | 507 |
ac immune | 274 |
curis | 256 |
xenon pharmaceuticals | 135 |
constellation pharmaceuticals | 109 |
novartis | 94 |
biogen idec ma | 89 |
forma tm | 75 |
genentech | 1643 |
roche | 62 |
array biopharma | 56 |
ac immune | 37 |
lexicon pharmaceuticals | 34 |
agensys | 13 |
curis | 11 |
novartis | 10 |
biogen idec ma | 8 |
tanox | 7 |
genentech | 1222 |
roche | 391 |
ac immune | 38 |
xenon pharmaceuticals | 37 |
array biopharma | 36 |
curis | 28 |
constellation pharmaceuticals | 16 |
exelixis | 11 |
rqx pharmaceuticals | 11 |
aimm therapeutics | 10 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
method to identify a patient with an increased likelihood of responding to an anti-cance… 🛈 | 109 | 2010 |
apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | 105 | 2009 |
combinations of akt inhibitor compounds and erlotinib, and methods of use | 101 | 2011 |
combinations of an anti-her2 antibody-drug conjugate and chemotherapeutic agents, and me… 🛈 | 91 | 2008 |
humanized antibody against amyloid beta | 87 | 2006 |
humanized anti-factor d antibodies | 81 | 2006 |
anti-cd79b antibodies and immunoconjugates and methods of use | 81 | 2007 |
antibody purification by cation exchange chromatography | 80 | 2007 |
inhibitors of iap | 78 | 2012 |
hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors | 77 | 2006 |